Alpha Teknova, Inc. (TKNO)

NASDAQ: TKNO · Real-Time Price · USD
6.37
+0.38 (6.34%)
May 8, 2025, 4:00 PM - Market closed
6.34%
Market Cap 340.39M
Revenue (ttm) 37.75M
Net Income (ttm) -26.75M
Shares Out 53.44M
EPS (ttm) -0.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,087,646
Open 5.93
Previous Close 5.99
Day's Range 5.85 - 6.81
52-Week Range 1.16 - 10.37
Beta 0.51
Analysts Buy
Price Target 5.00 (-21.51%)
Earnings Date May 8, 2025

About TKNO

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug di... [Read more]

Sector Healthcare
IPO Date Jun 25, 2021
Employees 173
Stock Exchange NASDAQ
Ticker Symbol TKNO
Full Company Profile

Financial Performance

In 2024, Alpha Teknova's revenue was $37.75 million, an increase of 2.89% compared to the previous year's $36.68 million. Losses were -$26.75 million, -27.28% less than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for TKNO stock is "Buy" and the 12-month stock price forecast is $5.0.

Price Target
$5.0
(-21.51% downside)
Analyst Consensus: Buy
Stock Forecasts

News

Teknova Reports First Quarter 2025 Financial Results

First quarter 2025 total revenue was $9.8 million, up 5% from prior year Company introduced proprietary PluriFreeze™  cryopreservation system, in collaboration with Pluristyx, Inc. Company reaffirms 2...

12 hours ago - GlobeNewsWire

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of n...

14 days ago - GlobeNewsWire

Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies

HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx's PluriFreeze™ cryopreservation system is avai...

7 weeks ago - GlobeNewsWire

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies

Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx's Novel PluriFreeze™ Cryopreservation System Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx's Novel...

2 months ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q4 2024 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call March 4, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executi...

2 months ago - Seeking Alpha

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidance Fourth quarter 2024 total revenue was $9.3 million, up 18% over the same quarter prior year Company provi...

2 months ago - GlobeNewsWire

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

2 months ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q3 2024 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO) Q3 2024 Earnings Conference Call November 7, 2024 5:30 PM ET Company Participants Jennifer Henry – Senior Vice President-Marketing Stephen Gunstream – President and ...

6 months ago - Seeking Alpha

Teknova Reports Third Quarter 2024 Financial Results

Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior year Company lowers 2024 total free cash outflow outlook to less than $16 million Company reaffirms 2024 revenue g...

6 months ago - GlobeNewsWire

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

7 months ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q2 2024 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO) Q2 2024 Earnings Conference Call August 13, 2024 5:00 PM ET Company Participants Jennifer Henry - SVP, Marketing Stephen Gunstream - President & CEO Matt Lowell - CF...

9 months ago - Seeking Alpha

Teknova Reports Second Quarter 2024 Financial Results

Second quarter 2024 total revenue was $9.6 million, up 3% sequentially Raised $15.4 million of equity capital in July 2024 Launched two new offerings: Express-TekSM Production and RUO+ manufacturing g...

9 months ago - GlobeNewsWire

Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024

HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

10 months ago - GlobeNewsWire

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

10 months ago - GlobeNewsWire

Teknova Announces $15.4 Million Private Placement

HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

10 months ago - GlobeNewsWire

Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results

Second quarter 2024 total revenue is in the range of $9.4 to $9.6 million Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, ...

10 months ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q1 2024 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO) Q1 2024 Earnings Conference Call May 13, 2024 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President and C...

1 year ago - Seeking Alpha

Teknova Reports First Quarter 2024 Financial Results

First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™  Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million

1 year ago - GlobeNewsWire

Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development

First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use in early-stage experiments, all with exceptionally shor...

1 year ago - GlobeNewsWire

Teknova to Report First Quarter 2024 Financial Results on May 13, 2024

HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of n...

1 year ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q4 2023 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2023 Earnings Conference Call March 11, 2024 5:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & C...

1 year ago - Seeking Alpha

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results

Full year 2023 total revenue was $36.7 million, down 11% year-over-year Achieved 36% annual growth in the number of Clinical Solutions customers in 2023 Company provides 2024 revenue guidance of $35-3...

1 year ago - GlobeNewsWire

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of no...

1 year ago - GlobeNewsWire

Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Teknova Reports Third Quarter 2023 Financial Results

Raised $22.9 million of equity capital, paid down $10.0 million of long-term debt Third quarter 2023 total revenue was $8.2 million, down 24% from prior year Expect 2023 revenue at the low end of prev...

1 year ago - GlobeNewsWire